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In an era of rapidly evolving and expanding endovascular
therapy, infrainguinal occlusive disease is increasingly being treated
with a variety of percutaneous modalities. Nevertheless, there is
still a significant patient population with critical limb ischemia
secondary to extensive infrainguinal occlusive disease beyond the
scope of endovascular intervention and for whom conventional
bypass surgery is the only hope for successful revascularization and
limb salvage. In light of the marked increase in the prevalence of
diabetes mellitus in our society, and with the long-term perfor-
mance of many of these endovascular interventions for infraingui-
nal disease still unknown, it is likely that infrainguinal bypass graft
surgery will remain an important part of the practice of vascular
surgery in the future.
The evidence is incontrovertible that the optimum infraingui-
nal bypass graft conduit is autogenous saphenous vein, and this is
especially true for infrapopliteal procedures. Even in the hands of
outstanding vascular surgeons, however, acute vein graft failure
occurs secondary to disadvantaged inflow or outflow, a suboptimal
conduit, or perioperative enhanced hypercoagulability states. For a
number of years it has been proposed by some that creation of an
adjunctive arteriovenous (AV) fistula would increase flow and thereby
enhance synthetic infrapopliteal synthetic bypass graft patency, and
the results have been mixed.
The current study represents the first report of the perfor-
mance of an adjuvant AV fistula to improve infrapopliteal vein graft
patency in the setting of disadvantaged outflow. The authors have
confirmed that creation of an AV fistula in this setting is a relatively
benign intervention. Unfortunately, this study has demonstrated
no apparent clinical benefit of this technique: Early and late graft
patency, and limb salvage, were not significantly improved in the
study population. As the authors acknowledge, the value of this
study is limited by its retrospective nature. Further, it is unfortu-
nate that the patency of the AV fistulae could not be documented,
because this is obviously a key parameter that might have influ-
enced the outcome and conclusions.
The authors are to be congratulated for this novel effort to
improve vein bypass graft patency and limb salvage in this demand-
ing patient population, for providing a control group against which
this technique can be reasonably compared, and for bringing in a
sense a “negative” outcome to the attention of our readership.
I would not give up on this technique yet. Rather, in view of the
limitations of this retrospective study, I would encourage them to
continue to investigate this strategy in a prospective randomized trial.
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